Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Comment by zwerp2000on Dec 14, 2022 6:18pm
140 Views
Post# 35172027

RE:RE:Everyone needs to relax!

RE:RE:Everyone needs to relax!Did xB3 fail, zwerp2000? Is that the program failure? The answer is pretty obvious. XB3 failed. This is why the company has been scambling around to keep solvent and why they eventually had to sell out for peanuts. Prothena looked at the platform and for years, did nothing with it. Chiesi came in and did nothing with it either. If there was any utility to XB3 someone would have come in and moved it forward but no one did. Certainly if there was utility, the ceo could have negotiated a better deal. The problem, as i said earlier, was that XB3 is a failure. The company had no money and no other options so they sold out for cheap in order to somewhat survive if you want to call it that

The ceo was unable to fulfill the promises she had made over the years. None of the programs she spoke of ever moved forward. As someone suggested, i do not know what she did to earn a salary. What did anyone do at this company to earn a salary? It doesn't appear anything was going on other then the ceo selling a fairy tale to its few remaining shareholders. 
<< Previous
Bullboard Posts
Next >>